![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Helix Receives FDA’s Emergency Use Authorization for its COVID-19 Test
Helix Receives FDA’s Emergency Use Authorization for its COVID-19 Test
San Mateo, Calif.-based Helix has been granted the FDA’s Emergency Use Authorization for its COVID-19 diagnostic, the Helix SARS-CoV-2 test.
The test is authorized for the qualitative detection of nucleic acid from the SARS-CoV-2 coronavirus in anterior nasal swab specimens.
The samples can be self-collected without supervision by adults age 18 and up who are suspected by their healthcare providers of having COVID-19 infections.
The kits may only be processed by two Helix laboratories in San Diego that are certified to perform the required high-complexity tests.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct